The only thing That I can come up with is it came out of bK and is an OTC. BUT I still don't understand how this company can have the fast track withe the FDA and still not much interest. Monday will be very telling.
Creditors have been selling shares since Biovest announced that they would be resolving their Bankruptcy issues. This recent pull back is a buying opportunity. Aren't they presenting at a conference next week in Orlando Fl? I believe that I read somewhere that BVTI is presenting Monday at a Hematology conference next week. I agree with your comment about shares of BVTI climbing back to $2 very quickly....GLTA
News 
Market Data 
Discover 
AI
